These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36936780)

  • 1. MFN1 augmentation prevents retinal degeneration in a Charcot-Marie-Tooth type 2A mouse model.
    Shahin S; Lu B; Zhou Y; Xu H; Chetsawang J; Baloh RH; Wang S
    iScience; 2023 Mar; 26(3):106270. PubMed ID: 36936780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoring mitofusin balance prevents axonal degeneration in a Charcot-Marie-Tooth type 2A model.
    Zhou Y; Carmona S; Muhammad AKMG; Bell S; Landeros J; Vazquez M; Ho R; Franco A; Lu B; Dorn GW; Wang S; Lutz CM; Baloh RH
    J Clin Invest; 2019 Mar; 129(4):1756-1771. PubMed ID: 30882371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Charcot-Marie Tooth Disease Mutation R94Q in MFN2 Decreases ATP Production but Increases Mitochondrial Respiration under Conditions of Mild Oxidative Stress.
    Wolf C; Zimmermann R; Thaher O; Bueno D; Wüllner V; Schäfer MKE; Albrecht P; Methner A
    Cells; 2019 Oct; 8(10):. PubMed ID: 31640251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complementation between mouse Mfn1 and Mfn2 protects mitochondrial fusion defects caused by CMT2A disease mutations.
    Detmer SA; Chan DC
    J Cell Biol; 2007 Feb; 176(4):405-14. PubMed ID: 17296794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitofusin 1 overexpression rescues the abnormal mitochondrial dynamics caused by the Mitofusin 2 K357T mutation in vitro.
    Stavropoulos F; Georgiou E; Schiza N; Bell S; Baloh RH; Kleopa KA; Sargiannidou I
    J Peripher Nerv Syst; 2023 Sep; 28(3):329-340. PubMed ID: 37220142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of mitofusin 2(R94Q) in a transgenic mouse leads to Charcot-Marie-Tooth neuropathy type 2A.
    Cartoni R; Arnaud E; Médard JJ; Poirot O; Courvoisier DS; Chrast R; Martinou JC
    Brain; 2010 May; 133(Pt 5):1460-9. PubMed ID: 20418531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel ENU-Induced
    Hines TJ; Bailey J; Liu H; Guntur AR; Seburn KL; Pratt SL; Funke JR; Tarantino LM; Burgess RW
    Biology (Basel); 2023 Jul; 12(7):. PubMed ID: 37508383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Finding a new balance to cure Charcot-Marie-Tooth 2A.
    Iwata K; Scorrano L
    J Clin Invest; 2019 Mar; 129(4):1533-1535. PubMed ID: 30882369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDAC6 inhibition promotes α-tubulin acetylation and ameliorates CMT2A peripheral neuropathy in mice.
    Picci C; Wong VSC; Costa CJ; McKinnon MC; Goldberg DC; Swift M; Alam NM; Prusky GT; Shen S; Kozikowski AP; Willis DE; Langley B
    Exp Neurol; 2020 Jun; 328():113281. PubMed ID: 32147437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioenergetic defect associated with mKATP channel opening in a mouse model carrying a mitofusin 2 mutation.
    Guillet V; Gueguen N; Cartoni R; Chevrollier A; Desquiret V; Angebault C; Amati-Bonneau P; Procaccio V; Bonneau D; Martinou JC; Reynier P
    FASEB J; 2011 May; 25(5):1618-27. PubMed ID: 21285398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined RNA interference and gene replacement therapy targeting MFN2 as proof of principle for the treatment of Charcot-Marie-Tooth type 2A.
    Rizzo F; Bono S; Ruepp MD; Salani S; Ottoboni L; Abati E; Melzi V; Cordiglieri C; Pagliarani S; De Gioia R; Anastasia A; Taiana M; Garbellini M; Lodato S; Kunderfranco P; Cazzato D; Cartelli D; Lonati C; Bresolin N; Comi G; Nizzardo M; Corti S
    Cell Mol Life Sci; 2023 Nov; 80(12):373. PubMed ID: 38007410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered interplay between endoplasmic reticulum and mitochondria in Charcot-Marie-Tooth type 2A neuropathy.
    Bernard-Marissal N; van Hameren G; Juneja M; Pellegrino C; Louhivuori L; Bartesaghi L; Rochat C; El Mansour O; Médard JJ; Croisier M; Maclachlan C; Poirot O; Uhlén P; Timmerman V; Tricaud N; Schneider BL; Chrast R
    Proc Natl Acad Sci U S A; 2019 Feb; 116(6):2328-2337. PubMed ID: 30659145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CMT2A-linked MFN2 mutation, T206I promotes mitochondrial hyperfusion and predisposes cells towards mitophagy.
    Das R; Maity S; Das P; Kamal IM; Chakrabarti S; Chakrabarti O
    Mitochondrion; 2024 Jan; 74():101825. PubMed ID: 38092249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitofusin gain and loss of function drive pathogenesis in
    El Fissi N; Rojo M; Aouane A; Karatas E; Poliacikova G; David C; Royet J; Rival T
    EMBO Rep; 2018 Aug; 19(8):. PubMed ID: 29898954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of mitofusin 2 mutations in the physiopathology of Charcot-Marie-Tooth disease type 2A.
    Cartoni R; Martinou JC
    Exp Neurol; 2009 Aug; 218(2):268-73. PubMed ID: 19427854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early onset Charcot-Marie-Tooth neuropathy type 2A and severe developmental delay: expanding the clinical phenotype of MFN2-related neuropathy.
    Tufano M; Cappuccio G; Terrone G; Manganelli F; Pisciotta C; Geroldi A; Capponi S; Del Giudice E
    J Peripher Nerv Syst; 2015 Dec; 20(4):415-8. PubMed ID: 26307494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitofusin 2 mutation drives cell proliferation in Charcot-Marie-Tooth 2A fibroblasts.
    Zanfardino P; Longo G; Amati A; Morani F; Picardi E; Girolamo F; Pafundi M; Cox SN; Manzari C; Tullo A; Doccini S; Santorelli FM; Petruzzella V
    Hum Mol Genet; 2023 Jan; 32(2):333-350. PubMed ID: 35994048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cohort study of Han Chinese MFN2-related Charcot-Marie-Tooth 2A.
    Lv H; Wang L; Zhang W; Wang Z; Zuo Y; Liu J; Yuan Y
    J Neurol Sci; 2015 Nov; 358(1-2):153-7. PubMed ID: 26382835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MFN2 Deficiency Impairs Mitochondrial Transport and Downregulates Motor Protein Expression in Human Spinal Motor Neurons.
    Mou Y; Dein J; Chen Z; Jagdale M; Li XJ
    Front Mol Neurosci; 2021; 14():727552. PubMed ID: 34602978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CMT2A Harboring Mitofusin 2 Mutation with Optic Nerve Atrophy and Normal Visual Acuity.
    Guerriero S; D'Oria F; Rossetti G; Favale RA; Zoccolella S; Alessio G; Petruzzella V
    Int Med Case Rep J; 2020; 13():41-45. PubMed ID: 32110117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.